: The FDA authorized the third antibody infusion therapy. Here’s why Vir and GSK say the U.S. still needs COVID-19 treatments


There are now three antibody-based treatments available in the U.S. to treat adults and teens with mild or moderate forms of COVID-19, though all require intravenous infusions and are not the kind of medications that can be picked up at a local pharmacy.

The Wall Street Journal: Bill Gates and Melinda French Gates are exploring structural changes to their foundation

Previous article

The Wall Street Journal: Boeing halts 787 Dreamliner deliveries due to production problems

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News